Influences of the circadian clock on neuronal susceptibility to excitotoxicity

Stroke is the third leading cause of death and the primary cause of morbidity in the United States, thus posing an enormous burden on the healthcare system. The factors that determine the risk of an individual toward precipitation of an ischemic event possess a strong circadian component as does the...

Full description

Bibliographic Details
Main Authors: Karmarkar, Sumedha W., Tischkau, Shelley A.
Format: Online
Language:English
Published: Frontiers Media S.A. 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817863/
id pubmed-3817863
recordtype oai_dc
spelling pubmed-38178632013-11-07 Influences of the circadian clock on neuronal susceptibility to excitotoxicity Karmarkar, Sumedha W. Tischkau, Shelley A. Physiology Stroke is the third leading cause of death and the primary cause of morbidity in the United States, thus posing an enormous burden on the healthcare system. The factors that determine the risk of an individual toward precipitation of an ischemic event possess a strong circadian component as does the ischemic event itself. This predictability provided a window of opportunity toward the development of chronopharmaceuticals which provided much better clinical outcomes. Experiments from our lab showed for the first time that neuronal susceptibility to ischemic events follows a circadian pattern; hippocampal neurons being most susceptible to an ischemic insult occurring during peak activity in a rodent model of global cerebral ischemia. We also demonstrated that the SCN2.2 cells (like their in vivo counterpart) are resistant to excitotoxicity by glutamate and that this was dependent on activation of ERK signaling. We are currently working on elucidating the complete neuroprotective pathway that provides a barricade against glutamate toxicity in the SCN2.2 cells. Our future experiments will be engaged in hijacking the neuroprotective mechanism in the SCN2.2 cells and applying it to glutamate-susceptible entities in an effort to prevent their death in the presence of excitotoxicity. Despite the advancement in chronopharmaceuticals, optimal clinical outcome with minimal adverse events are difficult to come by at an affordable price. Superior treatment options require a better understanding of molecular mechanisms that define the disease, including the role of the circadian clock. Frontiers Media S.A. 2013-11-05 /pmc/articles/PMC3817863/ /pubmed/24204346 http://dx.doi.org/10.3389/fphys.2013.00313 Text en Copyright © 2013 Karmarkar and Tischkau. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Karmarkar, Sumedha W.
Tischkau, Shelley A.
spellingShingle Karmarkar, Sumedha W.
Tischkau, Shelley A.
Influences of the circadian clock on neuronal susceptibility to excitotoxicity
author_facet Karmarkar, Sumedha W.
Tischkau, Shelley A.
author_sort Karmarkar, Sumedha W.
title Influences of the circadian clock on neuronal susceptibility to excitotoxicity
title_short Influences of the circadian clock on neuronal susceptibility to excitotoxicity
title_full Influences of the circadian clock on neuronal susceptibility to excitotoxicity
title_fullStr Influences of the circadian clock on neuronal susceptibility to excitotoxicity
title_full_unstemmed Influences of the circadian clock on neuronal susceptibility to excitotoxicity
title_sort influences of the circadian clock on neuronal susceptibility to excitotoxicity
description Stroke is the third leading cause of death and the primary cause of morbidity in the United States, thus posing an enormous burden on the healthcare system. The factors that determine the risk of an individual toward precipitation of an ischemic event possess a strong circadian component as does the ischemic event itself. This predictability provided a window of opportunity toward the development of chronopharmaceuticals which provided much better clinical outcomes. Experiments from our lab showed for the first time that neuronal susceptibility to ischemic events follows a circadian pattern; hippocampal neurons being most susceptible to an ischemic insult occurring during peak activity in a rodent model of global cerebral ischemia. We also demonstrated that the SCN2.2 cells (like their in vivo counterpart) are resistant to excitotoxicity by glutamate and that this was dependent on activation of ERK signaling. We are currently working on elucidating the complete neuroprotective pathway that provides a barricade against glutamate toxicity in the SCN2.2 cells. Our future experiments will be engaged in hijacking the neuroprotective mechanism in the SCN2.2 cells and applying it to glutamate-susceptible entities in an effort to prevent their death in the presence of excitotoxicity. Despite the advancement in chronopharmaceuticals, optimal clinical outcome with minimal adverse events are difficult to come by at an affordable price. Superior treatment options require a better understanding of molecular mechanisms that define the disease, including the role of the circadian clock.
publisher Frontiers Media S.A.
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817863/
_version_ 1612023525476925440